These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 30814488)
1. S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer. Liu S; Ni C; Zhang D; Sun H; Dong X; Che N; Liang X; Chen C; Liu F; Bai J; Lin X; Zhao X; Sun B Cell Death Dis; 2019 Feb; 10(3):200. PubMed ID: 30814488 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer. Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325 [TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry. Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077 [TBL] [Abstract][Full Text] [Related]
4. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells. Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487 [TBL] [Abstract][Full Text] [Related]
5. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter. Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281 [TBL] [Abstract][Full Text] [Related]
6. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer. Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171 [TBL] [Abstract][Full Text] [Related]
7. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms. Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Li ZY; Zhang RG; Zhu F; Wu G Int J Cancer; 2019 May; 144(9):2227-2238. PubMed ID: 30374974 [TBL] [Abstract][Full Text] [Related]
8. Endothelial cell sphingosine 1-phosphate receptor 1 restrains VE-cadherin cleavage and attenuates experimental inflammatory arthritis. Burg N; Malpass R; Alex L; Tran M; Englebrecht E; Kuo A; Pannelini T; Minett M; Athukorala K; Worgall T; Faust HJ; Goodman S; Mehta B; Brenner M; Vestweber D; Wei K; Blobel C; Hla T; Salmon JE JCI Insight; 2024 Jun; 9(11):. PubMed ID: 38855867 [TBL] [Abstract][Full Text] [Related]
9. Curcumin Inhibits Vasculogenic Mimicry Chong Y; Xu S; Liu T; Guo P; Wang X; He D; Zhu G Curr Cancer Drug Targets; 2024; 24(10):1031-1046. PubMed ID: 38299401 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells. Aikins AR; Kim M; Raymundo B; Kim CW Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861 [TBL] [Abstract][Full Text] [Related]
11. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells. Sahni A; Arévalo MT; Sahni SK; Simpson-Haidaris PJ Int J Cancer; 2009 Aug; 125(3):577-84. PubMed ID: 19358279 [TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells. Yeo C; Han DS; Lee HJ; Lee EO Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936664 [TBL] [Abstract][Full Text] [Related]
13. N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition. Pagano C; Navarra G; Pastorino O; Avilia G; Coppola L; Della Monica R; Chiariotti L; Florio T; Corsaro A; Torelli G; Caiazzo P; Gazzerro P; Bifulco M; Laezza C Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638872 [TBL] [Abstract][Full Text] [Related]
14. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma. Yang J; Lu Y; Lin YY; Zheng ZY; Fang JH; He S; Zhuang SM Cancer Lett; 2016 Dec; 383(1):18-27. PubMed ID: 27693460 [TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway. Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291 [TBL] [Abstract][Full Text] [Related]
16. TP53INP1 inhibits hypoxia-induced vasculogenic mimicry formation via the ROS/snail signalling axis in breast cancer. Wang Y; Sun H; Zhang D; Fan D; Zhang Y; Dong X; Liu S; Yang Z; Ni C; Li Y; Liu F; Zhao X J Cell Mol Med; 2018 Jul; 22(7):3475-3488. PubMed ID: 29655255 [TBL] [Abstract][Full Text] [Related]
17. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers. Bartolomé RA; Torres S; Isern de Val S; Escudero-Paniagua B; Calviño E; Teixidó J; Casal JI Oncotarget; 2017 Jan; 8(1):215-227. PubMed ID: 27966446 [TBL] [Abstract][Full Text] [Related]
18. Leptin Promotes Vasculogenic Mimicry in Breast Cancer Cells by Regulating Aquaporin-1. Han DS; Lee EO Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791252 [TBL] [Abstract][Full Text] [Related]
19. Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway. Xiao T; Zhong W; Zhao J; Qian B; Liu H; Chen S; Qiao K; Lei Y; Zong S; Wang H; Liang Y; Zhang H; Meng J; Zhou H; Sun T; Liu Y; Yang C Cell Death Dis; 2018 Sep; 9(9):906. PubMed ID: 30185783 [TBL] [Abstract][Full Text] [Related]
20. The effect of interleukin-17F on vasculogenic mimicry in oral tongue squamous cell carcinoma. Almahmoudi R; Salem A; Hadler-Olsen E; Svineng G; Salo T; Al-Samadi A Cancer Sci; 2021 Jun; 112(6):2223-2232. PubMed ID: 33743555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]